John C. Martin
2011 - Gilead Sciences
In 2011, John C. Martin earned a total compensation of $15.6M as Chairman and Chief Executive Officer at Gilead Sciences, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,788,500 |
|---|---|
| Option Awards | $5,863,222 |
| Salary | $1,423,354 |
| Stock Awards | $5,535,569 |
| Other | $5,000 |
| Total | $15,615,645 |
Martin received $5.9M in option awards, accounting for 38% of the total pay in 2011.
Martin also received $2.8M in non-equity incentive plan, $1.4M in salary, $5.5M in stock awards and $5K in other compensation.
Rankings
In 2011, John C. Martin's compensation ranked 139th out of 10,747 executives tracked by ExecPay. In other words, Martin earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 139 out of 10,747 | 99th |
Division Manufacturing | 43 out of 3,960 | 99th |
Major group Chemicals And Allied Products | 12 out of 1,033 | 99th |
Industry group Drugs | 7 out of 781 | 99th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 157 | 99th |
Source: SEC filing on March 24, 2014.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2011.